Welcome
Support Centre
21 March 2013 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes
statistics

[ Print-friendly version ]
Nephrectomy versus no nephrectomy for metastatic renal carcinoma
ISRCTN ISRCTN75184582
DOI 10.1186/ISRCTN75184582
ClinicalTrials.gov identifier
EudraCT number
Public title Nephrectomy versus no nephrectomy for metastatic renal carcinoma
Scientific title
Acronym N/A
Serial number at source RE03
Study hypothesis To establish whether, in patients with metastatic renal carcinoma, nephrectomy has any advantage.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Renal Cancer
Participants - inclusion criteria 1. Patient should have locally operable disease and should be fit enough for nephrectomy
2. A renal tumour with clinical or radiological evidence of metastases
3. No previous malignancy (except non-melanotic skin cancer or in situ carcinoma of the cervix)
4. Written informed consent of the patient
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/1995
Anticipated end date 01/12/1998
Status of trial Completed
Patient information material
Target number of participants 120
Interventions 1. One group receives a nephrectomy
2. The other receives no nephrectomy
Primary outcome measure(s) 1. Time to progression
2. Metastase rate
3. Quality of life
4. Survival time
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Medical Research Council (MRC) (UK)
Trial website
Publications
Contact name Mrs  Pat  Cook
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Email pat.cook@ctu.mrc.ac.uk
Sponsor Medical Research Council (MRC) (UK)
  Address 20 Park Crescent
  City/town London
  Zip/Postcode W1B 1AL
  Country United Kingdom
  Tel +44 (0)20 7636 5422
  Fax +44 (0)20 7436 6179
  Email clinical.trial@headoffice.mrc.ac.uk
  Sponsor website: http://www.mrc.ac.uk
Date applied 28/02/2001
Last edited 30/07/2012
Date ISRCTN assigned 28/02/2001
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2013 ISRCTN unless otherwise stated.